News About: Pharm. Industry
Re-use plan for asbestos-contaminated drugs likely to hit snag
Several pharmaceutical companies, including Ilyang Pharm, will hit snag with a plan to recover active ingredients from about 1,000 medicines that are confirmed to have used talc or talcum powders with asbestos, as the...
KPMA to gear up for fair competition
The Korea Pharmaceutical Manufacturers Association has renewed its incessant, diverse efforts to prevent illegal rebate practice.
It also said the association is willing to accept the readjustment of drug prices ba...
Institut Pasteur Korea, Sanofi-Aventis to promote tuberculosis drug screening
Institut Pasteur Korea (IPK) announced on October 7 that it has signed a research agreement with Sanofi-Aventis’s Research & Development Center in Toulouse, France for the identification of safe and effective new trea...
Boehringer Ingelheim Korea releases telmisartan and hydrochlorothiazide combination drug
Boehringer Ingelheim Korea says it has recently launched Micardis Plus (telmisartan 80mg/hydrochlorothiazide 25mg).
The combination drug is indicated for the treatment of mild to moderate hypertension in patients t...
Myungmoon to conduct bioequivalence testing on generic Tamiflu
Myungmoon Pham is waiting for approval to conduct bioequivalence test of their generic version of Tamiflu, according to the Korea Food and Drug Administration.
Chong Kun Dang Pharmaceutical and SK Chemicals have re...
37 local drugmakers spend 40% of revenue on promotion in 2008
Details of 37 Korea pharmaceutical firms’ promotional and sales expenses last year show that they spent 40.4 percent of their annual revenue on marketing and hospitality on average, according to the data.
Rep. Choi...
Oral PE treatment to go on sale in mid-October
Priligy (dapoxetine) will be a big hope for Korean patients with premature ejaculation (PE) as Janssen Korea is ready to market the drug in the middle of this month.
The local market prices for Priligy (dapoxetine)...
Medical advertising in TV will benefit only big hospitals
A lawmaker on October 6 characterized the proposed plan to permit medical institutions to reinvest profits on advertising and other marketing activities as a preferential measure in favor of large hospitals.
During...
SK, Janssen Korea to co-market Mvix
SK Chemicals and Janssen Korea has recently announced that the two companies signed an agreement to co-market Mvix, a new impotence drug, here from the latter half of next year.
MVIX is the 13th new drug developed ...
Leading drugmakers to seek sustained growth by strategic alliance with bioventure firms
To seek new growth amid tight competition, more and more local drug makers are teaming up with bioventure firms for joint tech development, according to pharmaceutical business sources.
For pharmaceutical companies...
